Claus Marsh is a UK pharmaceutical company established in 1992. Specializing in the manufacturing of high-quality innovative pharmaceuticals, over-the-counter (OTC) products, and food supplements, the company aims to provide better access to cost-effective healthcare while enhancing human health and well-being globally. Claus Marsh envisions being recognized as a world-class leader in the pharmaceutical industry with a global presence. Collaborating closely with leading scientists, physicians, and pharmaceutical partners, the company continually diversifies its portfolio by introducing new products annually across various therapeutic areas. With a mission to reduce healthcare expenses, Claus Marsh is dedicated to delivering innovative pharmaceutical solutions to customers worldwide.
Industries: Manufacturing, Pharmaceutical
While vital information such as the company headquarters, last investment, and last investment investors are not available at present, Claus Marsh's commitment to innovation and global healthcare accessibility presents an appealing opportunity for potential venture capital investors. The company's established presence in the pharmaceutical industry and its dedication to developing novel healthcare solutions positions it as an attractive prospect for investment, promising potential growth and impact within the global healthcare market.There is no investment information
No recent news or press coverage available for Claus Marsh.